Implementation of artesunate rectal capsules as a pre-referral intervention for severe malaria patients at community level in eight regions in Madagascar: a process evaluation

13 Jul 2021
MMV and Université de Fianarantsoa

Since WHO-prequalified artesunate rectal capsule 100 mg became available in Madagascar only in January 2019, cascade training and printable materials for community actors have been provided with the financial support of MMV. Community healthcare providers needed remotivating with on-site refresher
training on the use of artesunate rectal capsule. The aim of this interventional programme was to introduce the use of ARC in Madagascar, using a picture box, a checklist, a 4-page brochure and a poster raising awareness on pre-referral artesunate rectal capsule in children under 6 years old.